CASTLE BIOSCIENCES, INC. Income Taxes Paid
CASTLE BIOSCIENCES, INC. (CSTL) reported Income Taxes Paid of $1.60 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-02-26
- CASTLE BIOSCIENCES, INC. income taxes paid, net for the quarter ending 2019-12-31 was $0.00, a 100.00% decline year-over-year.
- CASTLE BIOSCIENCES, INC. income taxes paid, net for the quarter ending 2019-09-30 was $0.00, a 100.00% decline year-over-year.
- CASTLE BIOSCIENCES, INC. income taxes paid, net for the quarter ending 2018-12-31 was $644.00.
- CASTLE BIOSCIENCES, INC. income taxes paid, net for the quarter ending 2018-09-30 was $159.36K.
- CASTLE BIOSCIENCES, INC. income taxes paid, net for fiscal 2025 was $1.60M, a 36.04% decline from fiscal 2024.
- CASTLE BIOSCIENCES, INC. income taxes paid, net for fiscal 2024 was $2.50M, a 1164.14% increase from fiscal 2023.
- CASTLE BIOSCIENCES, INC. income taxes paid, net for fiscal 2023 was $198.00K, a 65.00% increase from fiscal 2022.
- CASTLE BIOSCIENCES, INC. income taxes paid, net for fiscal 2022 was $120.00K, a 650.00% increase from fiscal 2021.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|---|
| 2025-12-31 | $1.60M 10-K · filed 2026-02-26 | |||
| 2024-12-31 | $2.50M 10-K · filed 2026-02-26 | |||
| 2023-12-31 | $198.00K 10-K · filed 2026-02-26 | |||
| 2022-12-31 | $120.00K 10-K · filed 2025-02-27 | |||
| 2021-12-31 | $16.00K 10-K · filed 2023-02-28 | |||
| 2020-12-31 | $102.00K 10-K · filed 2022-02-28 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $0.00 derived: sum of 2 quarters · filed 2021-03-11 | -$150.00K 10-K · filed 2021-03-11 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$150.00K 10-Q · filed 2019-11-12 | ||
| 2019-06-30 | -$150.00K 10-Q · filed 2019-09-03 | |||
| 2018-12-31 | $644.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $160.00K derived: sum of 2 quarters · filed 2020-03-10 | $160.00K 10-K · filed 2020-03-10 | |
| 2018-09-30 | $159.36K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $159.36K 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | $0.00 10-Q · filed 2019-09-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |